F. Wessels
Papers
1
Total Citations
2
H-Index
1
About
F. Wessels is a clinical researcher whose work focuses on improving surgical outcomes in urologic oncology, particularly through innovative techniques to reduce postoperative complications. Their most notable contribution is the design and leadership of the PELYCAN study, a randomized controlled adaptive phase III trial comparing a peritoneal flap versus no flap for lymphocele prevention after robotic-assisted radical prostatectomy with pelvic lymph node dissection. This work addresses a critical clinical challenge—lymphocele formation—a common and morbid complication following pelvic lymph node dissection. By pioneering adaptive trial methodology in this surgical context, Wessels has advanced evidence-based practice in minimally invasive urologic surgery. Though their most-cited paper (2023) has garnered 2 citations to date, its impact is expected to grow as the field adopts these findings. Wessels’ research exemplifies the integration of rigorous trial design with practical surgical innovation, offering direct benefits to patients undergoing prostate cancer treatment. Their work underscores a commitment to reducing morbidity and improving recovery, positioning them as a rising contributor to urologic oncology and surgical outcomes research.
Research Focus
Key Achievements
Top Papers
- 1